Susan Elizabeth Arnold Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

Susan Elizabeth Arnold is SVP, Technical Operations of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 41,236 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 20, 2022, when has been sold 10,917 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $7,424. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.2K

0% 3M change

0% 12M change

Total Value Held $0

Susan Elizabeth Arnold Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2022	BUY Grant, award, or other acquisition	$7,424 $0.68 p/Share	10,917 Added 20.93%	41,236 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	$5,144 $2.01 p/Share	2,559 Added 7.78%	30,319 Common Stock
Jul 12 2021	BUY Grant, award, or other acquisition	$7,863 $1.74 p/Share	4,519 Added 14.0%	27,760 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	$14,720 $2.8 p/Share	5,257 Added 18.45%	23,241 Common Stock
Nov 20 2020	BUY Grant, award, or other acquisition	$14,496 $3.0 p/Share	4,832 Added 21.18%	17,984 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$6,236 $1.15 p/Share	5,423 Added 29.2%	13,152 Common Stock
Feb 27 2020	BUY Exercise of conversion of derivative security	$6,236 $1.15 p/Share	5,423 Added 41.23%	7,729 Common Stock

SEA

Susan Elizabeth Arnold

SVP, Technical Operations

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Value

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

Operation

Value

Type

News

Receive news related to PhaseBio Pharmaceuticals Inc

Track Activities on PHAS

Account